Kinesiotaping in Isolated Meniscus Injuries

May 4, 2026 updated by: Nurten NAS KIRDAR, Bandırma Onyedi Eylül University

The Effect of Kinesiotaping on Pain and Functionality in Isolated Meniscus Injuries: A Randomized Controlled Study

The effect of kinesiotaping on pain and functionality in isolated meniscus injuries.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Our study was designed as a randomized controlled trial. All patients presenting to the Physical Medicine and Rehabilitation outpatient clinic with knee pain and meeting the inclusion criteria will be included in the study after being informed and giving their consent. Patients' age, gender, and body mass index will be recorded. Patients will be divided into three groups using stratified randomization. An attempt will be made to ensure a homogeneous distribution of patients in terms of gender, age, and body mass index. Group 1 will receive standard treatment, Group 2 will receive standard treatment + kinesiotaping, and Group 3 will receive standard treatment + sham taping. Standard treatment will consist of strengthening exercises for the quadriceps and hamstring muscles, stretching exercises around the knee, proprioceptive exercises, and activity modification. These exercises will be taught to the patient and they will be asked to perform them at home five days a week for three weeks. Kinesiotaping and sham taping will be applied three times, once every five days. Kinesiotaping will be applied to the group with a specific tension and technique (quadriceps facilitation technique, "Y" tape shape, applied with 25-50% tension), while the sham group will have the tape simply applied to the skin without any tension (perpendicular to the quadriceps muscle, tension-free). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%). All patients will have VAS and WOMAC parameters evaluated before treatment, on day 20, and at month 3 after treatment.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
75

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Turkey (Türkiye)
      • Balıkesir, Turkey (Türkiye)
        • Recruiting
        • Bandırma Onyedi Eylul University Faculty of Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Ages 18-50
  • Knee pain lasting longer than 2 weeks
  • Having a diagnosis of isolated meniscus injury (grade 1, 2 or 3 meniscus degeneration) confirmed by magnetic resonance imaging (MRI)
  • Not having undergone knee surgery in the last 6 months
  • Not having received intraarticular injections in the knee area
  • Being willing to participate in the study

Exclusion Criteria:

  • Trauma history
  • Anterior or posterior cruciate ligament injury
  • Collateral ligament injuries
  • Advanced knee osteoarthritis
  • Rheumatic or neurological disease
  • Allergy or skin condition to kinesiotape
  • History of intraarticular injection
  • Neuromuscular dysfunction
  • Rheumatological disease
  • Cognitive dysfunction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Exercises
Standard treatment will consist of strengthening exercises for the quadriceps and hamstring muscles, stretching exercises around the knee, proprioceptive exercises, and activity modification. These exercises will be taught to the patient and they will be asked to perform them at home five days a week for three weeks.
Behavioral: Exercise
rengthening exercises for the quadriceps and hamstring muscles, stretching exercises around the knee, proprioceptive exercises, and activity modification.
Experimental: kinesiotaping
Kinesiotaping will be applied three times, once every five days. Kinesiotaping will be applied to the group with a specific tension and technique (quadriceps facilitation technique, "Y" tape shape, applied with 25-50% tension). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).
Procedure: kinesiotaping
Kinesiotaping will be applied three times, once every five days. Kinesiotaping will be applied to the group with a specific tension and technique (quadriceps facilitation technique, "Y" tape shape, applied with 25-50% tension). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).
Experimental: sham taping
Sham taping will be applied three times, once every five days. The sham group will have the tape simply applied to the skin without any tension (perpendicular to the quadriceps muscle, tension-free). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).
Procedure: sham taping
sham taping will be applied three times, once every five days. the sham group will have the tape simply applied to the skin without any tension (perpendicular to the quadriceps muscle, tension-free). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
VAS
Time Frame: 3 months
The VAS (Visual Analog Scale) will be used to determine the severity of knee pain. The VAS is a reliable and easily applicable scale accepted worldwide in the literature for measuring the severity of pain in patients. The Visual Analog Scale is used to convert values that cannot be measured numerically into numerical values. It is a scale where the starting point is -0- "no pain" and the other end is -10- "very severe pain," with numerical values assigned to each centimeter (cm) in one-centimeter increments.
3 months
WOMAC
Time Frame: 3 months
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a widely used, valid, and reliable index for evaluating patients with osteoarthritis. It is also very commonly used in knee problems other than osteoarthritis to assess knee pain and knee function. It is a recommended metric for osteoarthritis studies by the Outcome Measures in Rheumatology Clinical Trials (OMERACT). The WOMAC OA index, validated and proven reliable in Turkish by Tüzün et al., consists of three sections and 24 questions assessing pain, stiffness, and physical function. The maximum possible scores are 20 for the pain subgroup, 8 for stiffness, and 68 for physical function. Higher scores indicate increased pain and stiffness, and impaired physical function.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Bandırma Onyedi Eylül University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Nurten NAS KIRDAR, Assistant Professor, Bandırma Onyedi Eylül University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
October 30, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
October 30, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 28, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 4, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 7, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 7, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 4, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • E-67961857-050.04-2600014939

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Once our study is completed, if it is deemed suitable for evaluation and publication in a peer-reviewed journal on the subject, all researchers will be able to access our results.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Meniscus Injury

Clinical Trials on Exercise

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings